Lymphatics, cancer and zebrafish

Advances in Experimental Medicine and Biology

Volumn 916, Issue , 2016, Pages 199-218

  Astin, Jonathan W ^a   Crosier, Philip S ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cancer; Development; Lymphangiogenesis; Lymphatic; Tumor lymphatics; Vascular; Zebrafish

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; GREEN FLUORESCENT PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; POLYCYSTIC KIDNEY DISEASE 1ALPHA; PROTEIN KINASE B; PROTEIN PROX1; RAS PROTEIN; TRANSCRIPTION FACTOR SOX18; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ANATOMICAL CONCEPTS; CANCER GENETICS; CANCER TRANSPLANTATION; CELL FATE; CELL MIGRATION; ENDOTHELIUM CELL; GENETIC SCREENING; HUMAN; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; MALIGNANT NEOPLASTIC DISEASE; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSGENIC ZEBRAFISH; ANIMAL; DISEASE MODEL; GENETICS; NEOPLASM; PATHOLOGY; ZEBRA FISH;

ANIMALS; DISEASE MODELS, ANIMAL; LYMPHATIC VESSELS; NEOPLASMS; ZEBRAFISH;

EID: 84979026086     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-30654-4_9     Document Type: Chapter

References (102)

1. Tammela T, Alitalo K (2010) Lymphangiogenesis: molecular mechanisms and future promise. Cell 140:460–476
2. Sabin FR (1902) On the origin of the lymphatic system from the veins and the development of lymph hearts and the thoracic duct in the pig. Am J Anat 1:367–389
3. Srinivasan RS, Dillard ME, Lagutin OV, Lin FJ, Tsai S et al (2007) Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev 21:2422–2432
4. Koltowska K, Betterman KL, Harvey NL, Hogan BM (2013) Getting out and about: the emergence and morphogenesis of the vertebrate lymphatic vasculature. Development 140:1857–1870
5. Hewson W, Hunter W (1769) An account of the lymphatic system in fish. By the same. Philos Trans (1683–1775) 59:204–215
6. Kuchler AM, Gjini E, Peterson-Maduro J, Cancilla B, Wolburg H et al (2006) Development of the zebrafish lymphatic system requires VEGFC signaling. Curr Biol 16:1244–1248
7. Lawson ND, Weinstein BM (2002) In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 248:307–318
8. Yaniv K, Isogai S, Castranova D, Dye L, Hitomi J et al (2006) Live imaging of lymphatic development in the zebrafish. Nat Med 12:711–716
9. Okuda KS, Astin JW, Misa JP, Flores MV, Crosier KE et al (2012) lyve1 expression reveals novel lymphatic vessels and new mechanisms for lymphatic vessel development in zebrafish. Development 139:2381–2391
10. Bussmann J, Bos FL, Urasaki A, Kawakami K, Duckers HJ et al (2010) Arteries provide essential guidance cues for lymphatic endothelial cells in the zebrafish trunk. Development 137:2653–2657
11. van Impel A, Zhao Z, Hermkens DM, Roukens MG, Fischer JC et al (2014) Divergence of zebrafish and mouse lymphatic cell fate specification pathways. Development 141:1228–1238
12. Kampmeier OT (1969) Evolution and comparative morphology of the lymphatic system. Thomas, London
13. Coffindaffer-Wilson M, Craig MP, Hove JR (2011) Determination of lymphatic vascular identity and developmental timecourse in zebrafish (Danio rerio). Lymphology 44:1–12
14. Johnson NC, Dillard ME, Baluk P, McDonald DM, Harvey NL et al (2008) Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev 22:3282–3291
15. Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G et al (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21:1505–1513
16. Wigle JT, Oliver G (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98:769–778
17. Srinivasan RS, Geng X, Yang Y, Wang Y, Mukatira S et al (2010) The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev 24:696–707
18. Duong T, Koltowska K, Pichol-Thievend C, Le Guen L, Fontaine F et al (2013) VEGFD regulates blood vascular development by modulating SOX18 activity. Blood 123:1102–1112
19. Pendeville H, Winandy M, Manfroid I, Nivelles O, Motte P et al (2008) Zebrafish Sox7 and Sox18 function together to control arterial-venous identity. Dev Biol 317:405–416
20. Del Giacco L, Pistocchi A, Ghilardi A (2010) prox1b Activity is essential in zebrafish lymphangiogenesis. PLoS One 5:e13170
21. Coxam B, Sabine A, Bower NI, Smith KA, Pichol-Thievend C et al (2014) Pkd1 regulates lymphatic vascular morphogenesis during development. Cell Rep 7:623–633
22. Dunworth WP, Cardona-Costa J, Bozkulak EC, Kim JD, Meadows S et al (2014) Bone morphogenetic protein 2 signaling negatively modulates lymphatic development in vertebrate embryos. Circ Res 114:56–66
23. Aranguren XL, Beerens M, Vandevelde W, Dewerchin M, Carmeliet P et al (2011) Transcription factor COUP-TFII is indispensable for venous and lymphatic development in zebrafish and Xenopus laevis. Biochem Biophys Res Commun 410:121–126
24. Swift MR, Pham VN, Castranova D, Bell K, Poole RJ et al (2014) SoxF factors and Notch regulate nr2f2 gene expression during venous differentiation in zebrafish. Dev Biol 390:116–125
25. Geudens I, Herpers R, Hermans K, Segura I, Ruiz de Almodovar C et al (2010) Role of deltalike- 4/Notch in the formation and wiring of the lymphatic network in zebrafish. Arterioscler Thromb Vasc Biol 30:1695–1702
26. Fatima A, Culver A, Culver F, Liu T, Dietz WH et al (2014) Murine Notch1 is required for lymphatic vascular morphogenesis during development. Dev Dyn 243:957–964
27. Murtomaki A, Uh MK, Choi YK, Kitajewski C, Borisenko V et al (2013) Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endothelium. Development 140:2365–2376
28. Srinivasan RS, Escobedo N, Yang Y, Interiano A, Dillard ME et al (2014) The Prox1-Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors. Genes Dev 28:2175–2187
29. Hogan BM, Herpers R, Witte M, Helotera H, Alitalo K et al (2009) Vegfc/Flt4 signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries. Development 136:4001–4009
30. Astin JW, Haggerty MJ, Okuda KS, Le Guen L, Misa JP et al (2014) Vegfd can compensate for loss of Vegfc in zebrafish facial lymphatic sprouting. Development 141:2680–2690
31. Gordon K, Schulte D, Brice G, Simpson MA, Roukens MG et al (2013) Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema. Circ Res 112:956–960
32. Ober EA, Olofsson B, Makinen T, Jin SW, Shoji W et al (2004) Vegfc is required for vascular development and endoderm morphogenesis in zebrafish. EMBO Rep 5:78–84
33. Villefranc JA, Nicoli S, Bentley K, Jeltsch M, Zarkada G et al (2013) A truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and vascular development. Development 140:1497–1506
34. Hogan BM, Bos FL, Bussmann J, Witte M, Chi NC et al (2009) Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat Genet 41:396–398
35. Alders M, Hogan BM, Gjini E, Salehi F, Al-Gazali L et al (2009) Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet 41:1272–1274
36. Le Guen L, Karpanen T, Schulte D, Harris NC, Koltowska K et al (2014) Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis. Development 141:1239–1249
37. Jeltsch M, Jha SK, Tvorogov D, Anisimov A, Leppanen VM et al (2014) CCBE1 Enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation. Circulation 129:1962–1971
38. Fevurly RD, Hasso S, Fye A, Fishman SJ, Chan J (2012) Novel zebrafish model reveals a critical role for MAPK in lymphangiogenesis. J Pediatr Surg 47:177–182
39. Flores MV, Hall CJ, Crosier KE, Crosier PS (2010) Visualization of embryonic lymphangiogenesis advances the use of the zebrafish model for research in cancer and lymphatic pathologies. Dev Dyn 239:2128–2135
40. Kartopawiro J, Bower NI, Karnezis T, Kazenwadel J, Betterman KL et al (2014) Arap3 is dysregulated in a mouse model of hypotrichosis-lymphedema-telangiectasia and regulates lymphatic vascular development. Hum Mol Genet 23:1286–1297
41. Outeda P, Huso DL, Fisher SA, Halushka MK, Kim H et al (2014) Polycystin signaling is required for directed endothelial cell migration and lymphatic development. Cell Rep 7:634–644
42. Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in development and human disease. Nature 438:946–953
43. Clark ER, Clark EL (1937) Observations on living mammalian lymphatic capillaries–their relation to the blood vessels. Am J Anat 60:253–298
44. Cha YR, Fujita M, Butler M, Isogai S, Kochhan E et al (2012) Chemokine signaling directs trunk lymphatic network formation along the preexisting blood vasculature. Dev Cell 22:824–836
45. Lim AH, Suli A, Yaniv K, Weinstein B, Li DY et al (2011) Motoneurons are essential for vascular pathfinding. Development 138:3847–3857
46. Navankasattusas S, Whitehead KJ, Suli A, Sorensen LK, Lim AH et al (2008) The netrin receptor UNC5B promotes angiogenesis in specific vascular beds. Development 135:659–667
47. Sundlisaeter E, Dicko A, Sakariassen PO, Sondenaa K, Enger PO et al (2007) Lymphangiogenesis in colorectal cancer—prognostic and therapeutic aspects. Int J Cancer 121:1401–1409
48. Nathanson SD (2003) Insights into the mechanisms of lymph node metastasis. Cancer 98:413–423
49. Alitalo A, Detmar M (2012) Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 31:4499–4508
50. Dadras SS, Paul T, Bertoncini J, Brown LF, Muzikansky A et al (2003) Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162:1951–1960
51. Hoshida T, Isaka N, Hagendoorn J, di Tomaso E, Chen YL et al (2006) Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 66:8065–8075
52. Karnezis T, Shayan R, Caesar C, Roufail S, Harris NC et al (2012) VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 21:181–195
53. Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K et al (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109:1010–1017
54. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF et al (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201:1089–1099
55. Fukumura D, Duda DG, Munn LL, Jain RK (2010) Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. Microcirculation 17:206–225
56. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB et al (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296:1883–1886
57. Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB et al (2014) Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer 14:159–172
58. Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Yla-Herttuala S et al (2001) Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61:1786–1790
59. He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S et al (2002) Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94:819–825
60. Lin J, Lalani AS, Harding TC, Gonzalez M, Wu WW et al (2005) Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Res 65:6901–6909
61. Pytowski B, Goldman J, Persaud K, Wu Y, Witte L et al (2005) Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 97:14–21
62. Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K et al (2006) Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR- 2. Cancer Res 66:2650–2657
63. Debinski W, Slagle-Webb B, Achen MG, Stacker SA, Tulchinsky E et al (2001) VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme. Mol Med 7:598–608
64. Onogawa S, Kitadai Y, Tanaka S, Kuwai T, Kimura S et al (2004) Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci 95:32–39
65. Schietroma C, Cianfarani F, Lacal PM, Odorisio T, Orecchia A et al (2003) Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases. Cancer 98:789–797
66. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R et al (2002) Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161:947–956
67. He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T et al (2005) Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65:4739–4746
68. Farnsworth RH, Karnezis T, Shayan R, Matsumoto M, Nowell CJ et al (2011) A role for bone morphogenetic protein-4 in lymph node vascular remodeling and primary tumor growth. Cancer Res 71:6547–6557
69. Cao R, Ji H, Feng N, Zhang Y, Yang X et al (2012) Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis. Proc Natl Acad Sci U S A 109:15894–15899
70. Cao R, Bjorndahl MA, Religa P, Clasper S, Garvin S et al (2004) PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6:333–345
71. Bracher A, Cardona AS, Tauber S, Fink AM, Steiner A et al (2013) Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis. J Invest Dermatol 133:230–238
72. Lee AS, Kim DH, Lee JE, Jung YJ, Kang KP et al (2011) Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis. Cancer Res 71:4506–4517
73. Fagiani E, Lorentz P, Kopfstein L, Christofori G (2011) Angiopoietin-1 and -2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis. Cancer Res 71:5717–5727
74. Holopainen T, Saharinen P, D’Amico G, Lampinen A, Eklund L et al (2012) Effects of angiopoietin- 2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J Natl Cancer Inst 104:461–475
75. Karpinich NO, Kechele DO, Espenschied ST, Willcockson HH, Fedoriw Y et al (2013) Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis. FASEB J 27:590–600
76. Karpanen T, Wirzenius M, Makinen T, Veikkola T, Haisma HJ et al (2006) Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am J Pathol 169:708–718
77. Schulz MM, Reisen F, Zgraggen S, Fischer S, Yuen D et al (2012) Phenotype-based highcontent chemical library screening identifies statins as inhibitors of in vivo lymphangiogenesis. Proc Natl Acad Sci U S A 109:E2665–E2674
78. Zon LI, Peterson RT (2005) In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4:35–44
79. Astin JW, Jamieson SM, Eng TC, Flores MV, Misa JP et al (2014) An in vivo antilymphatic screen in zebrafish identifies novel inhibitors of Mammalian lymphangiogenesis and lymphatic- mediated metastasis. Mol Cancer Ther 13:2450–2462
80. Choi I, Chung HK, Ramu S, Lee HN, Kim KE et al (2011) Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse. Blood 117:362–365
81. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB et al (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199–6206
82. Rinderknecht M, Detmar M (2008) Tumor lymphangiogenesis and melanoma metastasis. J Cell Physiol 216:347–354
83. Shayan R, Karnezis T, Murali R, Wilmott JS, Ashton MW et al (2012) Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasis. Histopathology 61:702–710
84. Patton EE, Widlund HR, Kutok JL, Kopani KR, Amatruda JF et al (2005) BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 15:249–254
85. Dovey M, White RM, Zon LI (2009) Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish. Zebrafish 6:397–404
86. Santoriello C, Gennaro E, Anelli V, Distel M, Kelly A et al (2010) Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish. PLoS One 5, e15170
87. Anelli V, Santoriello C, Distel M, Koster RW, Ciccarelli FD et al (2009) Global repression of cancer gene expression in a zebrafish model of melanoma is linked to epigenetic regulation. Zebrafish 6:417–424
88. Park SW, Davison JM, Rhee J, Hruban RH, Maitra A et al (2008) Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology 134:2080–2090
89. Liu S, Leach SD (2011) Screening pancreatic oncogenes in zebrafish using the Gal4/UAS system. Methods Cell Biol 105:367–381
90. Zhu S, Lee JS, Guo F, Shin J, Perez-Atayde AR et al (2012) Activated ALK collaborates with MYCN in neuroblastoma pathogenesis. Cancer Cell 21:362–373
91. Li Z, Huang X, Zhan H, Zeng Z, Li C et al (2012) Inducible and repressable oncogeneaddicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish. J Hepatol 56:419–425
92. Nguyen AT, Emelyanov A, Koh CH, Spitsbergen JM, Parinov S et al (2012) An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening. Dis Model Mech 5:63–72
93. Haldi M, Ton C, Seng WL, McGrath P (2006) Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis 9:139–151
94. Nicoli S, Ribatti D, Cotelli F, Presta M (2007) Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res 67:2927–2931
95. Stoletov K, Kato H, Zardouzian E, Kelber J, Yang J et al (2010) Visualizing extravasation dynamics of metastatic tumor cells. J Cell Sci 123:2332–2341
96. Stoletov K, Montel V, Lester RD, Gonias SL, Klemke R (2007) High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci U S A 104:17406–17411
97. Marques IJ, Weiss FU, Vlecken DH, Nitsche C, Bakkers J et al (2009) Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 9:128
98. Langenau DM, Traver D, Ferrando AA, Kutok JL, Aster JC et al (2003) Myc-induced T cell leukemia in transgenic zebrafish. Science 299:887–890
99. Mizgireuv IV, Revskoy SY (2006) Transplantable tumor lines generated in clonal zebrafish. Cancer Res 66:3120–3125
100. Mizgirev I, Revskoy S (2010) Generation of clonal zebrafish lines and transplantable hepatic tumors. Nat Protoc 5:383–394
101. Smith AC, Raimondi AR, Salthouse CD, Ignatius MS, Blackburn JS et al (2010) Highthroughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia. Blood 115:3296–3303
102. Tang Q, Abdelfattah NS, Blackburn JS, Moore JC, Martinez SA et al (2014) Optimized cell transplantation using adult rag2 mutant zebrafish. Nat Methods 11:821–824